2023
1474. Getting to Zero: Our Journey to Decrease CABG Deep Sternal Wound Infections
Gentile P, Roberts S, Wilson E, Martinello R. 1474. Getting to Zero: Our Journey to Decrease CABG Deep Sternal Wound Infections. Open Forum Infectious Diseases 2023, 10: ofad500.1310. PMCID: PMC10676914, DOI: 10.1093/ofid/ofad500.1310.Peer-Reviewed Original ResearchDeep sternal wound infectionSternal wound infectionSSI bundleWound infectionSurgical site infection rateYale-New Haven HospitalCardiac thoracic surgeryCardiac surgery patientsRetrospective cohort reviewTime of surgeryHigher mortality riskNew Haven HospitalDSWI rateCohort reviewSurgery patientsSerious complicationsEndocrinology teamEpidemiologic evaluationThoracic surgeryMortality riskClinical decreaseConclusion ImplementationInfection rateSurgeryBathing practices
2021
Inpatient Capacity Management during COVID-19 Pandemic: The Yale New Haven Hospital Capacity Expansion Experience
Fogerty RL, Aniskiewicz M, Hedges T, Ryan S, Brien P, Beley P, Tangredi M, Mitchell M, d’Atri H, Jansen L, Williams E, LoRusso F, Sevilla M, Menillo J, Doyle D, Parrott H, Sheehan S, Martinello RA, Holmes M. Inpatient Capacity Management during COVID-19 Pandemic: The Yale New Haven Hospital Capacity Expansion Experience. Hospital Topics 2021, 100: 69-76. PMID: 34470597, DOI: 10.1080/00185868.2021.1926383.Peer-Reviewed Original Research
2019
2385. Evaluating the Antibiotic Risk for Clostridioides difficile Infection (CDI): Comparing Piperacillin/Tazobactam to Cefepime and Ceftazidime
Rathod S, McManus D, Rivera-Vinas J, Topal J, Martinello R. 2385. Evaluating the Antibiotic Risk for Clostridioides difficile Infection (CDI): Comparing Piperacillin/Tazobactam to Cefepime and Ceftazidime. Open Forum Infectious Diseases 2019, 6: s823-s824. PMCID: PMC6810941, DOI: 10.1093/ofid/ofz360.2063.Peer-Reviewed Original ResearchPiperacillin/tazobactamClostridioides difficile infectionMultivariate logistic regression modelCDI riskHealthcare-associated infectionsPTZ exposureLogistic regression modelsHospital admissionDifficile infectionΒ-lactam/β-lactamase inhibitorsCharlson Comorbidity Index scoreCommon healthcare-associated infectionsYale-New Haven HospitalComorbidity Index scoreAntibiotic stewardship effortsObservational cohort studyAntibiotic-associated diarrheaNew Haven HospitalFrequency of testingAnti-pseudomonal cephalosporinsCephalosporin therapyCohort studyΒ-lactamase inhibitorsAntibiotic therapySuppression therapy